Short Interest in Cansortium Inc. (OTCMKTS:CNTMF) Drops By 89.7%

Cansortium Inc. (OTCMKTS:CNTMFGet Free Report) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 1,900 shares, a decline of 89.7% from the January 31st total of 18,400 shares. Based on an average trading volume of 346,400 shares, the short-interest ratio is currently 0.0 days.

Cansortium Stock Performance

Cansortium stock traded up $0.00 during midday trading on Friday, hitting $0.06. 91,765 shares of the company were exchanged, compared to its average volume of 230,489. The company’s fifty day moving average price is $0.07 and its 200-day moving average price is $0.11. Cansortium has a fifty-two week low of $0.06 and a fifty-two week high of $0.25.

About Cansortium

(Get Free Report)

Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products.

Featured Articles

Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.